ArisGlobal and Sitero Expand Strategic Partnership to Advance AI Innovation across Literature Search & Monitoring and Case Management
Collaboration combines AI technology and operational expertise to help life sciences organizations ...
Webinar: Introducing Agentic AI for Signal Management

Signals Agents transform signal management by delivering a connected, real time safety view.
Webinar: The Rise of Intelligence Agents

AI Intelligence agents that interpret regulatory change and assess real-time impact.
Collaboration combines AI technology and operational expertise to help life sciences organizations ...
Modular, system-agnostic product design enables rapid deployment on top of existing safety systems ...
Expanding NavaX adoption, new Top Pharma wins, and continued global ...
New Distribution, Signals, and Intelligence Agents reduce manual effort, streamline compliance tasks, and orchestrate end-to-end decision workflows.
New NavaX-powered capabilities combine Dynamic Data Extraction, Translation, Conversational AI, and Intelligent Follow-up Management to modernize adverse event, medical information and product quality complaints reporting.
Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety ...
XDI brings the first federated solution for life sciences, collapsing data silos, unifying meaning, and ...
MADRID, SPAIN – February 11, 2026 – ArisGlobal, an AI-first technology company at ...
The Ukrainian pharmaceutical company modernizes regulatory operations with a centralized platform and multi-phase innovation strategy.
The latest deployment further highlights the momentum around production AI-driven NavaX implementations, and showcases the platform’s readiness for complex, character-based languages.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved